yingweiwo

New1

New1

New1 related products

Structure Cat No. Product Name CAS No. Product Description
AM-36 V10932 AM-36 199467-52-2 AM-36 is a novel and potent Na+ channel blocker, antioxidant agent
AM-4668 V8147 AM-4668 1011531-27-3 AM-4668 is a GPR40 agonist being studied in type 2 diabetes.
AM-5262 V10935 AM-5262 1222088-90-5 AM-5262 is a Potent GPR40 Full Agonist with improved rat PK profile and general selectivity profile.
AM-643 Free Acid V10937 AM-643 Free Acid 1233114-22-1 AM-643 Free Acid is a novel and potent bioactive compound
AM-6761 V10938 AM-6761 1584732-36-4 AM-6761 is a novel and potent inhibitor of the MDM2-p53
AM-679 V9466 AM-679 1206880-66-1 AM679 is a potent and specific inhibitor of 5-lipoxygenase-activating protein (FLAP) with IC50 of 2 nM in a human membrane binding assay.
AM-694 V10940 AM-694 335161-03-0 AM-694 is a novel and potent agonist for the cannabinoid receptor CB1
AM-8191 HCl V7643 AM-8191 HCl 1417548-17-4 AM8191 is an orally bioactive bactericide that selectively inhibits DNA synthesis and Staphylococcus aureus gyrase (IC50=1.02 μM) and topo IV (IC50=10.4 μM).
AM-8508 V6269 AM-8508 1338483-67-2 AM-8508 is a novel and potent PI3Kδ inhibitor
AM-8553 V10942 AM-8553 1352064-70-0 AM-8553 is an MDM2/p53 inhibitor (KD: 0.4 nM for MDM2).
AM-8735 V8814 AM-8735 1429386-01-5 AM-8735 is a potent and specific MDM2 inhibitor (antagonist) with IC50 of 25 nM.
AM-9514 V8276 AM-9514 1442677-18-0 AM-9514 is a novel and potent Glucokinase (GK) activator
AM-9635 V10944 AM-9635 1338483-10-5 AM-9635 is a novel and potent PI3Kδ inhibitor
AM-TS23 V11258 AM-TS23 1489285-17-7 Procaspase-IN-5 is a human DNA polymerase lambda inhibitor.
AM211 V10924 AM211 1175526-27-8 AM211 is a potent, selective, orally bioavailable prostaglandin receptor (DP2) antagonist (inhibitor) with IC50s of 4.9 nM, 7.8 nM, and 4.9 nM for human, mouse, guinea pig, and rat DP2, respectively.
AM281 V9208 AM281 202463-68-1 AM281 is a selective CB1 receptor blocker (antagonist) with IC50 of 9.91 nM.
AM4113 V10934 AM4113 614726-85-1 CB1 antagonist 2 Obtained from patent WO2016184310A1, the caimabinoid 1 (CB1) antagonist, compound 3, inhibits CB1 in vivo with IC50 of 25.5 nM.
AM6538 V8159 AM6538 1245626-00-9 AM6538 is a long-acting, high-affinity, pseudo-irreversible cannabinoid (CB) antagonist.
AM6701 V22556 AM6701 1010096-65-7 AM6701 is a potent FAAH/MAGL inhibitor (equivalent inhibition IC50= 1.2 nM) with neuro-protective (neuro-protection) effects.
AM7499 V6993 AM7499 1577226-19-7 AM7499 is a novel and potent cannabinoid receptor agonist
Contact Us